A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg
{"title":"重症急性呼吸综合征冠状病毒感染肾透析患者监测系统、演变及预后","authors":"A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg","doi":"10.16966/2380-5498.209","DOIUrl":null,"url":null,"abstract":"Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.","PeriodicalId":92052,"journal":{"name":"International journal of nephrology and kidney failure","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2\",\"authors\":\"A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg\",\"doi\":\"10.16966/2380-5498.209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.\",\"PeriodicalId\":92052,\"journal\":{\"name\":\"International journal of nephrology and kidney failure\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of nephrology and kidney failure\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.16966/2380-5498.209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of nephrology and kidney failure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.16966/2380-5498.209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2
Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
